» Articles » PMID: 24393837

Liver Transplantation for Alcoholic Liver Disease

Overview
Specialty Gastroenterology
Date 2014 Jan 8
PMID 24393837
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Alcoholic liver disease (ALD) is the major cause of life-threatening liver disease in Western countries. Abstinence from alcohol is the foundation of all treatment programmes for patients with ALD. Liver transplantation is a valuable option for patients with life-threatening ALD. Although the role of liver transplantation in the treatment of alcoholic hepatitis that is unresponsive to medical therapy is controversial, the latest prospective studies support this approach. No single measure gives a reliable estimate of the risk of drinking relapses before or after liver transplantation, but careful evaluation by an addiction specialist with a particular interest in transplant medicine is the best available approach. Survival, both on the waiting list and after the operation, is better in patients with ALD than in patients with HCV infection. Alcohol relapse may lead to liver damage and increased mortality, albeit usually after many years of renewed drinking. After liver transplantation, patients with ALD have increased rates of mortality and morbidity that are attributable to cardiovascular disease and new-onset cancers of the aerodigestive tract. The latter are probably linked to the high prevalence of smoking in this population. Cessation of smoking is thus an important goal in the care of patients with ALD after they have undergone liver transplantation.

Citing Articles

The mediating role of social support in self-management and quality of life in patients with liver cirrhosis.

Zhang Y, Xiao L, Liu Q, Zhang X, Li M, Xu Y Sci Rep. 2025; 15(1):4758.

PMID: 39922844 PMC: 11807096. DOI: 10.1038/s41598-024-81943-5.


Non-cirrhotic Ascites: A Case of Severe Alcoholic Hepatitis.

Ebrahim M, Zaher E, Patel P, Ahmed M, Ahmed K Cureus. 2024; 16(4):e58187.

PMID: 38741864 PMC: 11089831. DOI: 10.7759/cureus.58187.


Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse.

Daniel J, Dumortier J, Del Bello A, Gamon L, Molinari N, Faure S JHEP Rep. 2023; 5(10):100832.

PMID: 37681206 PMC: 10480527. DOI: 10.1016/j.jhepr.2023.100832.


Effects of empowerment education on the self-management and self-efficacy of liver transplant patients: a randomized controlled trial.

Guo L, Li L, Lu Y, Li T, Chen L, Jiang L BMC Nurs. 2023; 22(1):146.

PMID: 37118749 PMC: 10140724. DOI: 10.1186/s12912-023-01298-6.


Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure.

Morales R, Bolarin J, Muro M, Legaz I Diagnostics (Basel). 2023; 13(7).

PMID: 37046435 PMC: 10093628. DOI: 10.3390/diagnostics13071217.